共 50 条
- [11] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - CHANGES IN THE REVIEW PROCESS FOR ANTIARTHRITIS DRUGS - LABELING OF ANALGESICS ARTHRITIS AND RHEUMATISM, 1989, 32 (10): : 1328 - 1329
- [15] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - METHOTREXATE - GUIDELINES FOR THE CLINICAL-EVALUATION OF ANTIINFLAMMATORY DRUGS - DMSO IN SCLERODERMA ARTHRITIS AND RHEUMATISM, 1986, 29 (10): : 1289 - 1290
- [19] FDA ARTHRITIS ADVISORY-COMMITTEE MEETING - RISKS OF AGRANULOCYTOSIS APLASTIC-ANEMIA, FLANK PAIN, AND ADVERSE GASTROINTESTINAL EFFECTS WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ARTHRITIS AND RHEUMATISM, 1987, 30 (05): : 593 - 595